デフォルト表紙
市場調査レポート
商品コード
1563414

コンシューマーヘルスケアの市場規模、シェア、成長分析、製品別、流通チャネル別、地域別 - 産業予測、2024年~2031年

Consumer Healthcare Market Size, Share, Growth Analysis, By Product (OTC Pharmaceuticals, Personal Care Products), By Distribution Channel (Online, Offline), By Region - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 219 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.96円
コンシューマーヘルスケアの市場規模、シェア、成長分析、製品別、流通チャネル別、地域別 - 産業予測、2024年~2031年
出版日: 2024年09月26日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

コンシューマーヘルスケアの世界市場規模は、2022年に2,810億米ドルと評価され、2023年の3,023億6,000万米ドルから2031年には5,432億7,000万米ドルに成長し、予測期間中(2024年~2031年)のCAGRは7.60%で成長する見通しです。

コンシューマーヘルスケアには、ウェルネス、オーラルケア、栄養、皮膚の健康など幅広い製品が含まれます。これらの商品の多くは、ビタミンやミネラルサプリメントなどの一般用医薬品(OTC)に該当し、処方箋を必要とせずに消費者に直接販売されます。一般的なOTC製品には、各種歯磨き粉、マウスウォッシュ、目薬、イボ取り、抗生物質入りの応急クリームや軟膏、フケ防止シャンプーなどがあります。世界コンシューマーヘルスケア市場の主要促進要因の一つは、健康状態に影響を受けやすい高齢者人口の増加であり、そのためOTC製品の需要が増加しています。しかし、不正確な、あるいは低品質の有効医薬品成分(API)を含む偽造品の存在が市場の成長を妨げるという課題に直面しています。世界各国の政府は、こうした偽造品の製造・販売を抑制するためのイニシアチブを実施しており、それによって信頼性が高く信用できるコンシューマーヘルスケアアイテムの成長が促進されています。さらに、ヘルスケアコストの上昇により、消費者は処方薬に代わるより手頃な価格のものを選ぶようになっており、コンシューマーヘルスケア市場に大きな成長機会を提供しています。従来の小売からオンライン・ショッピング・プラットフォームへの移行が進んでいることも、市場参入企業に有望な展望を与えています。PharmEasy、vitacost.com、healthkart.com、MedlinePlus、vivavitamins.comのようなウェブサイトは、ビタミン製品、プロテイン飲料、サプリメントを幅広く提供しており、消費者がオンラインでヘルスケア製品にアクセスすることを容易にしています。

目次

イントロダクション

  • 調査の目的
  • 定義
  • 市場範囲

調査手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模予測
  • 市場の想定と制限

エグゼクティブサマリー

  • 市場概要見通し
  • 供給需要動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主な市場の考察

  • 技術分析
  • 価格分析
  • 市場のエコシステム
  • ケーススタディ分析
  • 規制情勢
  • イノベーションマトリクス
  • 主な投資の分析
  • 主な成功要因
  • 競合の程度

コンシューマーヘルスケア市場:製品別

  • 市場概要
  • 市販薬
  • パーソナルケア製品
  • 栄養補助食品

コンシューマーヘルスケア市場:流通チャネル別

  • 市場概要
  • オンライン
  • オフライン
    • スーパーマーケットとハイパーマーケット
    • 薬局
    • その他

コンシューマーヘルスケア市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Teva Pharmaceutical Industries Limited(Israel)
  • Abbott Laboratories(US)
  • GlaxoSmithKline plc(UK)
  • Sanofi S.A.(France)
  • BASF SE(Germany)
  • Boehringer Ingelheim International GmbH(Germany)
  • Amway Corp.(US)
  • Pfizer Inc.(US)
  • Bayer AG(Germany)
  • Johnson & Johnson(US)
  • Reckitt Benckiser Group plc(UK)
  • Nestle Health Science(Switzerland)
  • Procter & Gamble Co.(US)
  • Unilever plc(UK)
  • Novartis AG(Switzerland)
  • Herbalife Nutrition Ltd.(US)
  • DSM Nutritional Products(Netherlands)
  • Himalaya Global Holdings Ltd.(India)
  • Perrigo Company plc(Ireland)
  • Merck KGaA(Germany)
  • Dabur India Ltd.(India)
  • Sun Pharmaceutical Industries Ltd.(India)
目次
Product Code: SQMIG35D2021

Global Consumer Healthcare Market size was valued at USD 281 billion in 2022 and is poised to grow from USD 302.36 billion in 2023 to USD 543.27 billion by 2031, growing at a CAGR of 7.60% during the forecast period (2024-2031).

Consumer healthcare encompasses a wide range of products, including those for wellness, oral care, nutrition, and skin health. Many of these items fall under over-the-counter (OTC) medications, such as vitamins and mineral supplements, which are sold directly to consumers without the need for a prescription. Common OTC products include various types of toothpaste, mouthwash, eye drops, wart removers, first aid creams and ointments with antibiotics, and anti-dandruff shampoos. One key driver of the global consumer healthcare market is the growing elderly population, which is more susceptible to health conditions, thus increasing the demand for OTC products. However, the market faces challenges due to the presence of counterfeit products containing inaccurate or low-quality active pharmaceutical ingredients (API), which hamper market growth. Governments worldwide are implementing initiatives to curb the production and sale of these counterfeit products, thereby fostering the growth of reliable and trusted consumer healthcare items. Additionally, rising healthcare costs are prompting consumers to opt for more affordable alternatives to prescription medications, offering a significant growth opportunity for the consumer healthcare market. The increasing shift from traditional retail to online shopping platforms also presents promising prospects for market participants. Websites like PharmEasy, vitacost.com, healthkart.com, MedlinePlus, and vivavitamins.com offer a wide array of vitamin products, protein drinks, and supplements, making it easier for consumers to access healthcare products online.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Consumer Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Consumer Healthcare Market Segmental Analysis

Global Consumer Healthcare Market is segmented by Product, Distribution Channel, and region. Based on Product, the market is segmented into OTC Pharmaceuticals, Personal Care Products, and Dietary Supplements. Based on Distribution Channel, the market is segmented into Online, and Offline. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Consumer Healthcare Market

Today, people are increasingly prioritizing their health and are actively seeking innovative ways to maintain their well-being. As a result, many consumers are turning to self-medication as their first line of defense against common health issues, rather than seeking alternative treatments. This shift has significantly boosted the demand for preventative healthcare products, particularly over-the-counter (OTC) medications, which have seen substantial growth in the global consumer healthcare market. Self-medication offers the convenience of easy access to OTC drugs at a lower cost, making it a more affordable and quicker option than expensive and time-consuming clinical visits. For instance, individuals experiencing minor health issues like nasal congestion, cold, or cough can easily purchase inhalers, tablets, or balms from a store without the need for a prescription. Moreover, these self-medication products are widely available, even in rural areas, ensuring that a broader population has access to essential healthcare solutions.

Restraints in the Global Consumer Healthcare Market

The misuse, overuse, and abuse of readily available over-the-counter (OTC) drugs pose significant challenges to the growth of the global consumer healthcare market. It is not uncommon for consumers worldwide to misuse these medications, using them in ways that differ from their intended purposes. For instance, the Consumer Healthcare Products Association (CHPA) has noted a concerning trend where a small but increasing number of individuals abuse loperamide to self-manage opioid withdrawal or to achieve a euphoric high. In addition to this, reports have surfaced of individuals using OTC drugs recreationally, further highlighting the risks of improper usage. Such misuse not only endangers consumer health but also presents legal and financial risks for manufacturers, who may be held accountable for product harm in various cases, even if the drugs are not used as intended. These issues, if left unchecked, could negatively impact the consumer healthcare market's reputation and growth prospects.

Market Trends of the Global Consumer Healthcare Market

People worldwide are becoming increasingly health-conscious, recognizing the impact of personal lifestyle choices on both their own health and that of others. This growing awareness is driving a shift in how individuals approach healthcare, encouraging them to take ownership of their well-being and explore ways to improve and maintain their health independently. This trend towards self-health advocacy is expected to fuel growth in the consumer healthcare market across multiple sectors. Additionally, self-care practices can help reduce the strain on healthcare systems and government resources by empowering individuals to manage their health proactively. As more people adopt self-care routines, the demand for consumer healthcare products, particularly over-the-counter solutions and preventative care, is likely to rise, further contributing to market expansion.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Ecosystem of the Market
  • Case study Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Consumer Healthcare Market by Product

  • Market Overview
  • OTC Pharmaceuticals
  • Personal Care Products
  • Dietary Supplements

Consumer Healthcare Market by Distribution Channel

  • Market Overview
  • Online
  • Offline
    • Supermarkets and Hypermarkets
    • Pharmacies
    • Others

Consumer Healthcare Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Teva Pharmaceutical Industries Limited (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi S.A. (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BASF SE (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim International GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amway Corp. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Reckitt Benckiser Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nestle Health Science (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Procter & Gamble Co. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Unilever plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Herbalife Nutrition Ltd. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DSM Nutritional Products (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Himalaya Global Holdings Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Perrigo Company plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dabur India Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sun Pharmaceutical Industries Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments